CN1294578A - 新的萘基和酰苯胺取代的磺酰胺 - Google Patents

新的萘基和酰苯胺取代的磺酰胺 Download PDF

Info

Publication number
CN1294578A
CN1294578A CN99804366A CN99804366A CN1294578A CN 1294578 A CN1294578 A CN 1294578A CN 99804366 A CN99804366 A CN 99804366A CN 99804366 A CN99804366 A CN 99804366A CN 1294578 A CN1294578 A CN 1294578A
Authority
CN
China
Prior art keywords
maximum
carbon atoms
group
alkyl
representative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99804366A
Other languages
English (en)
Chinese (zh)
Inventor
W·本德
J·雷夫施莱格
P·埃肯贝尔格
S·戈德曼
M·海特
S·哈伦贝尔格
J·特拉佩
O·维贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1294578A publication Critical patent/CN1294578A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN99804366A 1998-01-23 1999-01-09 新的萘基和酰苯胺取代的磺酰胺 Pending CN1294578A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802439 1998-01-23
DE19802439.8 1998-01-23

Publications (1)

Publication Number Publication Date
CN1294578A true CN1294578A (zh) 2001-05-09

Family

ID=7855411

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99804366A Pending CN1294578A (zh) 1998-01-23 1999-01-09 新的萘基和酰苯胺取代的磺酰胺

Country Status (30)

Country Link
US (1) US6417181B1 (enExample)
EP (1) EP1049666B1 (enExample)
JP (1) JP2002501043A (enExample)
KR (1) KR20010034321A (enExample)
CN (1) CN1294578A (enExample)
AR (1) AR016978A1 (enExample)
AT (1) ATE242207T1 (enExample)
AU (1) AU2420799A (enExample)
BG (1) BG104617A (enExample)
BR (1) BR9907738A (enExample)
CA (1) CA2318182A1 (enExample)
CO (1) CO4810231A1 (enExample)
DE (1) DE59905829D1 (enExample)
EE (1) EE200000432A (enExample)
ES (1) ES2201666T3 (enExample)
GT (1) GT199900010A (enExample)
HR (1) HRP20000532A2 (enExample)
HU (1) HUP0200918A2 (enExample)
ID (1) ID25448A (enExample)
IL (1) IL137159A0 (enExample)
NO (1) NO20003601L (enExample)
NZ (1) NZ505900A (enExample)
PE (1) PE20000181A1 (enExample)
PL (1) PL341815A1 (enExample)
SK (1) SK11012000A3 (enExample)
SV (1) SV1999000006A (enExample)
TR (1) TR200002140T2 (enExample)
TW (1) TW461880B (enExample)
WO (1) WO1999037609A1 (enExample)
ZA (1) ZA99473B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964941B (zh) * 2004-06-04 2010-06-16 宝洁公司 有机活化剂
CN112062901A (zh) * 2020-08-14 2020-12-11 合肥工业大学 一种螺旋荧光异腈共聚物及其制备方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919793A1 (de) * 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19934295A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Kristallmodifikation III von N-(4-(5-Dimethylamino-naphthalin-1-sulfonyl-amino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid
DE19934321A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Naphthyl-substituierte Sulfonamide
EP1402890B1 (en) * 2001-06-08 2008-01-09 Institute of Medicinal Molecular Design, Inc. Sulfonamide derivatives
US7598418B2 (en) * 2002-04-18 2009-10-06 Institute Of Medicinal Molecular Design, Inc. Amide derivatives
EP1590327A1 (en) 2002-12-23 2005-11-02 Millennium Pharmaceuticals, Inc. Ccr8 inhibitors
TW200510311A (en) 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
RU2452490C1 (ru) * 2010-12-27 2012-06-10 Виктор Вениаминович Тец Лекарственное средство с активностью против семейства герпес-вирусов
WO2013167743A1 (en) 2012-05-11 2013-11-14 Akron Molecules Gmbh Use of compounds for the treatment of pain
RU2530587C1 (ru) 2013-06-07 2014-10-10 Виктор Вениаминович Тец Способ лечения заболеваний кожи и слизистых оболочек, вызываемых вирусами простого герпеса 1-го и 2-го типов
RU2605602C1 (ru) 2015-09-15 2016-12-27 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения натриевой соли (2,6-дихлорфенил)амида карбопентоксисульфаниловой кислоты

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2423572A (en) * 1946-05-03 1947-07-08 Du Pont Naphtholsulfonamidobenzaldehydes and acetals thereof
US2949479A (en) * 1954-06-17 1960-08-16 Dainippon Pharmaceutical Co Acyl derivatives of aminonaphthalene-sulfonamide
US3482971A (en) 1967-07-24 1969-12-09 Polaroid Corp Scavengers for oxidized developing agent
US3925347A (en) 1967-07-24 1975-12-09 Polaroid Corp Processes of synthesizing azo compounds
US4035401A (en) 1970-03-30 1977-07-12 Polaroid Corporation Intermediates for photographic dyes
JPS5499433A (en) 1978-01-20 1979-08-06 Konishiroku Photo Ind Co Ltd Dye image formation method
EP0284130B1 (en) 1987-03-19 1991-06-26 Agfa-Gevaert N.V. Organic compounds for use in a dye diffusion transfer process and photographic elements incorporating them
WO1990009787A1 (en) * 1989-02-27 1990-09-07 The Du Pont Merck Pharmaceutical Company Novel sulfonamides as radiosensitizers
DE4331134A1 (de) 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame Pseudopeptide
EP0684515A1 (en) 1994-05-27 1995-11-29 Eastman Kodak Company Photographic element and process incorporating a high dye-yield image coupler providing improved granularity

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964941B (zh) * 2004-06-04 2010-06-16 宝洁公司 有机活化剂
CN112062901A (zh) * 2020-08-14 2020-12-11 合肥工业大学 一种螺旋荧光异腈共聚物及其制备方法
CN112062901B (zh) * 2020-08-14 2023-03-21 合肥工业大学 一种螺旋荧光异腈共聚物及其制备方法

Also Published As

Publication number Publication date
ES2201666T3 (es) 2004-03-16
DE59905829D1 (de) 2003-07-10
EP1049666A1 (de) 2000-11-08
TW461880B (en) 2001-11-01
JP2002501043A (ja) 2002-01-15
SV1999000006A (es) 2000-10-09
CO4810231A1 (es) 1999-06-30
SK11012000A3 (sk) 2001-01-18
NZ505900A (en) 2002-02-01
NO20003601L (no) 2000-09-14
ZA99473B (en) 1999-07-27
HUP0200918A2 (en) 2002-09-28
CA2318182A1 (en) 1999-07-29
GT199900010A (es) 2000-07-15
KR20010034321A (ko) 2001-04-25
AR016978A1 (es) 2001-08-01
WO1999037609A1 (de) 1999-07-29
PE20000181A1 (es) 2000-04-12
BG104617A (en) 2001-04-30
AU2420799A (en) 1999-08-09
BR9907738A (pt) 2000-10-17
ATE242207T1 (de) 2003-06-15
EP1049666B1 (de) 2003-06-04
PL341815A1 (en) 2001-05-07
NO20003601D0 (no) 2000-07-13
TR200002140T2 (tr) 2000-12-21
IL137159A0 (en) 2001-07-24
US6417181B1 (en) 2002-07-09
HRP20000532A2 (en) 2001-02-28
ID25448A (id) 2000-10-05
EE200000432A (et) 2001-12-17

Similar Documents

Publication Publication Date Title
CN1218936C (zh) 甲酰胺取代的苯基脲衍生物以及用于将其作为药物的制备方法
CN1151836C (zh) 用作传送活性剂的化合物和组合物
CN1294578A (zh) 新的萘基和酰苯胺取代的磺酰胺
CN1138472C (zh) 二肽型编程性细胞死亡抑制剂及其用途
CN1148350C (zh) 新型VLA-4抑制剂:oMePUPA-V
HK1042295A1 (zh) 1h-咪唑並吡啶衍生物
HK1045513A1 (zh) 環烷基取代的苯並咪唑、它們的製備及其用途
CN1181753A (zh) 新的具有速激肽受体拮抗活性的取代的哌嗪衍生物
CN1053230A (zh) 新的聚4-氨基-2-羟基-1-甲基化合物脲基衍生物的制备方法
CN1198096A (zh) 用于治疗与胶原蛋白过量产生有关的疾病的c－蛋白酶抑制剂
CN1370159A (zh) 吲哚衍生物和其在治疗骨质疏松中的应用以及其它应用
CN1384827A (zh) 茚并一,萘并一和苯并环庚二氢噻唑衍生物,它们的制备以及它们作为降低食欲药的用途
CN1206213C (zh) N－芳基磺酰氨基酸ω－酰胺
JPH07118217A (ja) 抗ウイルス活性を持つ新規擬ペプチド
CN1212835C (zh) 含异羟肟酸酯的半胱氨酸和丝氨酸蛋白酶抑制剂
CN1104209A (zh) 2，4-二氨基-3-羟基羧酸衍生物
CN1227230C (zh) Nmda受体配体的前药
CN1045778A (zh) 取代的(喹啉-2-基甲氧基)苯基-n，n′-磺酰脲、其制备方法及其在药物中之应用
CN1406233A (zh) 用于病毒性疾病的药物
JP2005526690A (ja) ヘテロシクリルアリールスルホンアミド類
CN1486298A (zh) 兴奋性氨基酸前体药物
CN1200932C (zh) 具有腺苷摄取抑制作用的取代的苯基环己烷甲酰胺
CN1209352C (zh) 肼衍生物
CN1863769A (zh) 氨基吡咯烷衍生物的制备方法和中间体化合物
CN1088912A (zh) 4-氨基-3-羟基羧酸衍生物

Legal Events

Date Code Title Description
BB1A Publication of application
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication